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Abstract
 .We characterized the ontogeny of cAMP-dependent protein kinase PKA enzymatic activity and PKA subunit mRNA
expression in developing lung. The lungs of fetal Sprague–Dawley rat pups were removed after 16, 18, or 20 days of
gestation and at term. PKA activity was greatest in the 18- and 20-day gestation lungs. Tissue cAMP levels were lowest in
the 16-day lungs and increased with lung maturity. We were able to detect only low levels of mRNA for the Cb subunit of
PKA by northern blot analysis of total lung RNA and we were able to detect mRNA for the RIb and RIIb subunits only by
RT-PCR. Therefore, we limited our analysis of PKA subunit mRNA levels to those for Ca , RIa and RIIa . The mRNA
levels for Ca , were highest in the 16-day lung, decreased at 18 and 20 days, were lower in the newborn and lowest in the
adult lung. RIa mRNA levels were also highest at 16 days and lowest in the adult lung. However, RIIa mRNA levels
were similar in the 18-day, 20-day and newborn lungs. Dexamethasone treatment of fetal lung explants resulted in a small
decrease in RIa mRNA levels but was not associated with a change in PKA activity. We conclude that PKA activity and
PKA subunit mRNA expression are developmentally regulated in fetal lung. Such regulation results in optimal PKA activity
at the time of type II alveolar cell differentiation, presumably in preparation for air breathing. The absence of an effect of
glucocorticoid on PKA activity suggests that glucocorticoids are not responsible for the increase in PKA activity which
accompanies this critical time in lung maturation. q 1998 Elsevier Science B.V.
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1. Introduction
 .Cyclic adenosine monophosphate cAMP and fac-
tors which increase intracellular cAMP levels have
been demonstrated to promote lung development and
alveolar type II cell differentiation in vivo and in
w xvitro. Barrett et al. 1 demonstrated that treatment of
pregnant rabbits with aminophylline resulted in an
increase in fetal lung cAMP levels and an associated
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w14 xincrease in C -choline incorporation into surfactant
specific disaturated phosphatidylcholine. b-adren-
ergic agonists, which activate adenylyl cyclase and
increase intracellular cAMP, increase pulmonary sur-
w xfactant production and secretion in adult rats 2 and
w xfetal sheep 3 . The treatment of perfused adult rat
lungs with the cAMP analog, 8-Br-cAMP, results in
an increase in alveolar levels of the type II cell
specific, surfactant-associated protein, SP-A, and an
associated increase in tissue levels of SP-A mRNA
w x4 . We have previously reported that prostaglandins
stimulate alveolar type II cell differentiation in hu-
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man fetal lung in vitro through an increase in tissue
w xproduction of cAMP 5 . The direct effect of cAMP
analogs to accelerate type II cell differentiation and
to stimulate production of the surfactant-associated
w xprotein, SP-A, in rat fetal lung 6 and human fetal
w xlung 7 in culture has also been demonstrated.
Cyclic AMP is a ubiquitous regulatory molecule
important for the induction of transcription of many
w xeukaryotic genes 8 . The downstream actions of
cAMP are dependent upon its binding to cAMP-de-
 . w xpendent protein kinase PKA 9 . PKA is a te-
 .trameric holoenzyme composed of two regulatory R
 .and two catalytic C subunits which dissociate upon
binding cAMP into an R-subunit dimer and two
w xactive C-subunits 10 . There are two types of PKA
holoenzymes, type I and type II, each distinguished
 .  .by its type I RI or type II RII regulatory subunit.
The primary function of the regulatory subunit is to
bind and inactivate the catalytic subunit in the ab-
w xsence of cAMP 11 . Two isoforms of each regulatory
subunit, designated RIa , RIb , RIIa and RIIb , have
w x w xbeen identified and cloned. RIa 12 and RIIa 13
are expressed in most cells, whereas the expression of
w x w xRIb 14 and RIIb 15 is more limited. The type II
holoenzyme has been reported by Giembycz and
Diamond to be the dominant form of PKA in adult
guinea pig lung, however, the subtype of the R
w xsubunits were not determined 16 . The specific regu-
latory subunit isoforms present in developing lung
have not been determined. Three isoforms of the C
subunit, designated Ca , Cb , and Cg , have also been
w xdescribed 17 . The Ca and Cb isoforms are ex-
pressed in adult human lung, whereas the Cg isoform
w xis expressed only in the testis 17 .
The objective of the current investigation was to
test the hypothesis that PKA activity and PKA sub-
unit mRNA expression is developmentally regulated
in lung tissue. We characterized the ontogeny of the
cAMP second messenger system in developing rat
lung by determining PKA activity, mRNA levels for
the PKA subunits, Ca , RIa and RIIa , and tissue
cAMP levels in whole homogenates of fetal, neonatal
and adult rat lung. Though we detected only low
levels of Cb mRNA by northern blot analysis and
were able to detect RIb and RIIb mRNA only by
RT-PCR, we found that mRNA levels for the other
PKA subunits changed during development in a pat-
tern consistent with changes in PKA activity. A
number of factors including glucocorticoids, epider-
mal growth factor, prostaglandins, cAMP analogs and
thyroid hormone are known to stimulate fetal lung
w xmaturation in vivo and in vitro 18–20 . Of these
factors, glucocorticoids are frequently used clinically
to induce maturation of the human fetal lung. There-
fore, it was also of interest to determine if PKA
activity and PKA subunit mRNA levels are regulated
by the synthetic glucocorticoid, dexamethasone, in rat
fetal lung explants maintained in vitro.
2. Materials and methods
2.1. Tissues for study and organ culture
Fetal, neonatal and adult lung tissue from timed-
 .pregnant Sprague–Dawley rats Sasco, Omaha, NE
were harvested, flash frozen in liquid N and stored2
at y708C for later processing. For studies involving
the in vitro effects of dexamethasone on steady state
levels of PKA subunit mRNA, 18-day gestation rat
fetal lung tissues were harvested and placed in ex-
plant culture as previously described for human fetal
w xlung explants 21 . Briefly, fetal lung tissues were
dissected free of major blood vessels and airways,
minced into 1–2-mm3 pieces with a sterile scalpel
blade and placed in organ culture. Cultures were
maintained for 48 h in serum-free Waymouth’s
 .MB752r1 medium, GIBCO, Grand Island, NY at
378C in the absence or presence of dexamethasone
 .100 nM . The media was replaced after 24 h of
incubation. Pooled lung tissues from one or two
litters were used for each experiment.
2.2. Assay of cAMP-dependent protein kinase acti˝ity
Fetal lung tissues for PKA activity assays were
harvested as above or, if maintained in vitro, tissues
were harvested after 48 h of incubation then frozen in
liquid N and stored at y708C until assays were2
performed. Tissues were homogenized in 0.5 ml of
 .10 mM NaPO pH 7.0 , 1 mM EDTA, 1 mM4
dithiothreitol, 0.1 mM isobutylmethyl xanthine, and
0.1 mM phenylmethylsulfonyl fluoride and cen-
trifuged for 15 min at 12 000=g. The supernatant
was collected and a protein determination by the
w xmethod of Bradford 22 was performed. The super-
natant was assayed for PKA activity as described by
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w x w xRoskoski 23 and modified by Howard et al. 24 .
Reaction mixtures containing 10 mg of supernatant
w32 x  .protein, 0.1 mM P ATP 200 cpmrpmol and 20
 .mM kemptide Sigma Chemical, St. Louis, MO in a
 .total volume of 50 ml 25 mM Tris–HCl pH 7.4
buffer were incubated at 308C for 5 min. Next, 20 ml
of reaction mixture was spotted onto phosphocellu-
 .lose paper Whatman P-81 and the papers were
washed four times in 75 mM phosphoric acid. Ra-
dioactivity was then determined by scintillation spec-
trometry. Assays were performed in duplicate or
triplicate for each incubation condition within each
experiment. Data are expressed as the rate of phos-
 .phorylation of the target peptide kemptide per mi-
 .crogram of protein assayed pmolrminrmg protein .
Each experiment was performed three to six times.
2.3. RNA isolation and analysis
Total RNA was isolated by the method of Chirg-
w xwin et al. 25 and quantitated by determining the
absorbance at 260 nm. Ten micrograms of total RNA
for each sample was separated on a 1.2%
agaroserformaldehyde gel then transferred by vac-
 .uum blotting Bio-Rad Laboratories, Hercules, CA
to a Nytran membrane Schleicher and Schuell,
.Keene, NH for northern blot analysis. The agarose
gels were stained with ethidium bromide to verify
complete transfer of RNA to the membranes. The
RNA was cross-linked to membranes by irradiation
with a hand-held UV light source for 5 min then
baked at 808C for 90 min. Membranes were prehy-
bridized at 428C for 6–12 h in hybridization buffer
w  . BSA 0.2% wtrvol , polyvinylpyrrolidone 0.2%,
.  . wtrvol , ficoll 0.2%, wtrvol , Tris–HCl 50 mM,
.  .pH 7.4 , Na pyrophosphate 0.1%, wtrvol , sodium
 . dodecyl sulfate 1%, wtrvol , formamide 50%,
.  . volrvol , dextran sulfate 10%, wtrvol , NaCl 1
.  .xM , and denatured salmon sperm DNA 100 mgrml .
The membranes were hybridized at 428C overnight in
hybridization buffer containing 1=106 cpmrml of
32P-labelled cDNA specific for rat Ca , RIa , or RIIa
mRNA cDNAs were kind gifts of Dr. Richard Mau-
rer, Oregon Health Sciences University, Portland,
. w xOR 26 . After hybridization, the blots were washed
twice for 5 min at room temperature in 2=SSC
w  .  . xNaCl 300 mM , sodium citrate 30 mM , pH 7.0 ,
twice for 30 min at 428C in 1=SSC plus sodium
 .dodecyl sulfate 1%, wtrvol , and once for 15 min at
room temperature in 0.1=SSC. Blots were exposed
to X-ray film with an intensifier screen at y708C for
24–72 h. Blots were stripped and reprobed with a
32P-labelled cDNA specific for 18S rRNA. Autora-
diograms of the hybridized blots were quantified by
scanning densitometry. Values were corrected for
RNA loading and transfer errors by adjustment to the
relative amounts of 18S rRNA. Plotted values for the
Ca , RIa and RIIa mRNA levels during gestation
 .Fig. 3B were normalized to the levels determined
for the ‘Adult’ lung.
2.4. Cyclic AMP assays
Whole rat lung tissues which had been flash frozen
were homogenized in 0.5 ml of buffer containing 0.1
 .M NaPO pH 7.4 , 0.1 mM EDTA, 0.1 mM dithio-4
threitol, 0.1 mM phenylmethylsulfonyl fluoride and
 .0.1 mM isobutylmethyl xanthine. An aliquot 20 ml
of each homogenate was removed for analysis of
w xprotein content by the method of Bradford 22 and
 .another aliquot 300 ml was boiled in a water bath
for 10 min. The boiled homogenates were then cen-
trifuged for 15 min at 12 000=g. Cyclic AMP levels
were determined in the supernatants by radioim-
munoassay with a commercially available kit
 .Amersham, Arlington Heights, IL . Cyclic AMP
levels were determined in triplicate for each sample
and values are expressed as pmol of cAMPrmg of
tissue protein. Determinations of tissue cAMP con-
tent were made on four different sets of tissues.
2.5. Re˝erse transcription–polymerase chain reac-
tion
Total RNA isolated from whole rat lung or adult
rat brain was incubated with oligo-dt primer Pro-
.mega, Madison, WI and avian myeloblastosis virus
 .reverse transcriptase Promega to generate first strand
 .cDNA for polymerase chain reaction PCR amplifi-
cation of RIb , RIIb and b-actin cDNA. PCR condi-
tions were optimized for each set of primers with a
 .PRC Optimizere kit Invitrogen, San Diego, CA .
Reaction mixtures of 50 ml total volume containing
10 ml 5= sample buffer PCR Optimizere kit,
buffer ‘G’ for RIb , buffer ‘C’ for RIIb , and buffer
.‘N’ for b-actin , 5 ml dimethyl sulfoxide, specific
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primers, dNTPs, Taq DNA polymerase Boehringer
.Mannheim , and H O were amplified for 35 cycles2
after preheating the PCR reaction mixtures to 948C
for 2 min. For amplification of RIb cDNA, a for-
ward primer 5X-CTACTGTGAAGGCCAAAACG-3X,
and reverse primer 5X-CAGGATCTCAGAGCAG-
GGG-3X generating a 461 bp product were employed
with each cycle being 948C for 1 min, annealing at
498C for 1 min, and 728C for 1 min. For amplifica-
tion of RII b , a forward primer 5X-TG -
GTGCTCTGTGGGGTTT-3X, and reverse primer 5X-
ATAATTTCCATGCAAGGTCCC-3X generating a
453 bp product were employed with each cycle as
above except for an annealing temperature of 518C
for 1 min. For amplification of b-actin, commercially
 .available primers Research Genetics, Huntsville, AL
were employed yielding a 289 bp product. The RT-
PCR was performed on three separate sets of total
RNA with similar results from each set. Total RNA
from adult rat brain served as a positive control.
2.6. Statistical analysis
Statistical comparisons of the densitometric mRNA
w xdata were made using a two-tailed Dunnett’s test 27 .
Other data were analyzed by one way ANOVA.
Comparisons between individual groups were made
Fig. 1. PKA activity in homogenates of whole lung from
Sprague–Dawley rats of 16-, 18-, 20-day gestation, term new-
 .  .  .born NB , 14-day neonate 14 dNB and adult A . Values
 .  .represent mean"SEM ns5 , ) P -0.05 vs. adult A , †P -
0.05 vs. 14 dNB.
Fig. 2. Tissue levels of cAMP in whole lung tissues from
Sprague–Dawley rats of 16-, 18-, 20-day gestation, term new-
 .  .  .born NB , 14-day neonate 14 dNB and adult A . Values
 .  .represent mean"SEM ns4 , ) P s0.07 vs. adult A .
with the paired t-test as appropriate. Differences were
considered significant when P-0.05.
3. Results
3.1. PKA acti˝ity in de˝eloping rat lung
PKA activity was determined in homogenates of
whole lung from Sprague–Dawley rats of 16-, 18-,
 .20-day gestation, term newborn 22 day gestation ,
 .14-day neonatal and adult Fig. 1 . PKA activity was
greatest in the 18-day and 20-day gestation fetal lung
Fig. 3. Presence of RIb and RIIb mRNA in developing rat lung
detected by RT-PCR. Total RNA from fetal, newborn and adult
rat lung was amplified by RT-PCR as demonstrated on this
representative ethidium bromide-stained agarose gel. Lane 1:
 .DNA ladder; Lane 2: H O negative control ; Lane 3: 16-day2
fetal lung; Lane 4: 18-day fetal lung; Lane 5: 20-day fetal lung;
Lane 6: newborn lung; Lane 7: adult lung; Lane 8: adult rat brain
 .positive control ; Lane 9: DNA ladder.
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and was significantly higher in fetal lung at all stages
examined and in the newborn lung when compared to
the adult lung. These findings suggest the develop-
mental regulation of PKA activity with the greatest
activity occurring in late gestation, perhaps, in prepa-
ration of neonatal life. Immunostaining was per-
formed for the Ca and RIa subunits to determine if
cell-type specific changes in the expression of these
subunits might occur during lung development in
association with our observed changes in PKA activ-
ity. However, Ca and RIa subunits were found to
be evenly distributed across all cell types throughout
 . development data not shown Jeanne M. Snyder,
.personal communication .
As demonstrated in Fig. 2, cAMP levels also
changed in association with rat lung development.
Cyclic AMP levels were lowest in the 16-day fetal
lungs and increased with lung maturation.
3.2. PKA mRNA le˝els in de˝eloping lung
We initially attempted to study the ontogeny of
mRNA levels for both the a and b subunits for C,
RI and RII, however, we were able to detect only low
levels of mRNA for Cb and we were unable to
detect mRNA for RIb and RIIb by northern blot
analysis of total lung RNA. Therefore, we performed
RT-PCR to determine if RIb and RIIb subunit
 .Fig. 4. Northern blot analysis of PKA subunit mRNAs. Total RNA 10 mg from the lungs of 16-, 18-, 20-day gestation, term newborn
 .  .  .NB , and adult A Sprague–Dawley rats was analyzed by northern blots using labelled cDNAs specific for rat Ca , RIa , RIIa . A A
 .representative autoradiogram. B Relative levels of mRNA for PKA subunits determined by scanning densitometry and corrected for
 .loading and transfer errors with desitometric values for 18S rRNA. Values are expressed as mean"SEM ns3–5 . ) P-0.05
 .compared to adult A condition.
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Table 1
Effect of regulatory factors on PKA subunit mRNA in rat fetal
lung in vitro
Ca mRNA RIa mRNA SP-A mRNA
Control 1.00 1.00 1.00
) ) .Dex 100 nM 0.91"0.14 0.81"0.06 1.38"0.06
Explants of 18-day rat fetal lung were placed in culture for 48 h
 .in the absence or presence of dexamethasone Dex . Densitomet-
ric values are relative to mRNA levels in the control tissues.
Values are expressed as the mean"SEM for three independent
experiments. )P -0.05 vs. control.
mRNA are expressed in the developing rat lung Fig.
.3 . RIb mRNA was undetectable at 16 days of
gestation but was detectable at 18 days of gestation
and later. In contrast, RIIb mRNA was detectable by
RT-PCR in the fetal and adult lung at 16 days of
gestation and at all other ages which were assessed
 .Fig. 3 . Because of the difficulty in detecting and
quantitating the PKA b-subunit mRNAs, we limited
further analysis of PKA subunit mRNA levels to
those for Ca , RIa and RIIa . We found that mRNA
levels for rat Ca were highest in 16-day fetal rat
lung and decreased through gestation Fig. 4A and
.B . However, Ca mRNA levels were significantly
higher in fetal and newborn lung tissues than in adult
rat lung tissues. Ca mRNA levels in 16-day fetal
lung were four-fold greater and newborn levels were
two-fold greater than levels in adult rat lung Fig.
.4B . Northern blotting for RIa yielded bands at 1.6
 .kb and a doublet at 3.0r3.2 kb Fig. 4A . The
multiple bands are known to be products of alterna-
w xtive polyadenylation site signalling 28 . Analysis of
several blots revealed little variation in the 3.0r3.2
kb doublet with development, with the exception of
the adult lung for which the 3.0r3.2 doublet mRNA
was approximately 50% of the level observed at all
other developmental time points. However, there were
significant changes in the RIa 1.6 kb mRNA signal
 .with gestation and these were quantitated Fig. 4B .
 .RIa mRNA 1.6 kb levels in 16-day fetal lung were
nearly six-fold greater, and newborn levels were
three-fold greater, than levels in adult rat lung Fig.
.4B . In contrast, RIIa mRNA levels, though higher
in 16-day fetal and newborn lung compared to the
adult lung, were not significantly different in 18- and
20-day fetal lungs when compared to the adult Fig.
.4 . Together, these data demonstrate that PKA mRNA
subunit levels are developmentally regulated in rat
lung.
3.3. Effect of glucocorticoid on PKA subunit mRNA
le˝els in rat fetal lung in ˝itro
In order to determine if glucocorticoids might
affect steady state levels of PKA subunit mRNAs, we
incubated rat fetal lung explants in the absence or
 .presence of dexamethasone 100 nM . This concen-
tration of dexamethasone has previously been demon-
strated to influence tissue morphology, surfactant pro-
tein levels and surfactant phospholipid production in
w xfetal lung in vitro 18 . As shown in Table 1, we
found that the steady state levels of mRNA for Ca
were not changed by 48 h of incubation in the
presence dexamethasone. However, RIa mRNA lev-
els were significantly decreased by 19% compared to
 .  .levels in untreated control tissues Table 1 . Steady
state levels of mRNA for the surfactant associated
protein, SP-A, were determined to serve as a positive
control. SP-A mRNA levels were increased in the
dexamethasone treated tissues as previously reported
w x6 .
In order to determine if the effect of hormone
treatment on RIa mRNA levels is associated with
changes in PKA activity in fetal lung explants, we
Fig. 5. Effect of dexamethasone on PKA activity. Rat fetal lung
 .explants were incubated for 48 h in the absence Con or
 .presence of dexamethasone Dex . PKA activity was then deter-
mined. Values represent the mean"SEM for four independent
experiments performed in duplicate. There was no significant
difference between the two conditions.
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determined PKA activity in explants after 48 h of
 .exposure to dexamethasone Fig. 5 . PKA activity
was unchanged in tissues treated with dexametha-
sone. PKA activity assays on tissues incubated in the
absence or presence of dexamethasone for 0, 0.5, 2,
4, 8, 12, 24, 36, and 48 h also failed to demonstrate
significant changes in PKA activity associated with
 .glucocorticoid treatment data not shown .
4. Discussion
Cyclic AMP-dependent protein kinase mediates
the intracellular actions of cAMP via phosphorylation
w xof specific target proteins. Whitsett et al. 29 have
previously demonstrated ontogenic changes in cAMP
enhanced phosphorylation by PKA of cytosolic pro-
teins in the lungs of developing rats. The activation
of PKA by terbutaline and forskolin in isolated type
II cells with an associated secretion of phosphatidyl-
choline has also been demonstrated by Rice et al.
w x30 . The importance of the PKA mediated effects of
cAMP in developing lung have been further studied
w xby Ballard et al. 31 , who found that mRNA levels
for the surfactant associated proteins, SP-A and SP-B,
decrease in human fetal lung explants treated with
H-8, an inhibitor of PKA activity. These studies
demonstrate the direct participation of PKA in cAMP
regulated events in the developing lung and in type II
alveolar cells.
In the present study, we defined the ontogeny of
PKA activity, tissue cAMP levels and PKA subunit
mRNA levels during rat lung development. We found
that PKA activity was greatest in 18- and 20-day fetal
lung, the period of rat alveolar type II cell differentia-
w xtion 32 , and decreased in the 14-day newborn and
adult lung. Importantly, our finding of maximal PKA
activity in the 20-day whole fetal lung is similar to
previous data demonstrating maximal endogenous
PKA activity in isolated rat type II cells at 20 days of
w xgestation 33 . Consistent with our finding of de-
creased PKA activity in the adult lung, cAMP levels,
which have been demonstrated by Richardson et al.
w x26 to down-regulate PKA activity via degradation
of Ca protein, were lowest in the early gestation
lung and increased with lung maturity. In contrast to
cAMP levels, but similar to PKA activity, mRNA
levels for Ca , and RIa decreased through gestation
and were significantly lower in the adult lung com-
pared to all earlier periods. RIIa mRNA levels,
however, varied to a lesser degree during gestation
than did the Ca and RIa mRNA levels but were still
significantly greater in the newborn lung than in the
adult lung. These data demonstrate the developmental
regulation of the cAMPrPKA system in rat lung.
The inverse relationship between cAMP levels and
PKA activity in later development supports the possi-
bility that cAMP may negatively regulate PKA activ-
ity in the developing lung as it does in tumor cell
w xlines 26 . However, as the effect of cAMP on PKA
activity occurs via a post-transcriptional mechanism,
changes in cAMP levels with lung development do
not account for the observed changes in PKA subunit
mRNA levels. These changes may occur secondary to
unidentified hormonal modulation, or, perhaps to
changes in the cell types which produce these mR-
NAs. Observing changes in the cellular distribution
of PKA subunits is difficult as PKA is a ubiquitous
enzyme. Immunohistochemical studies of the local-
ization of the Ca and RIa subunits of PKA have
shown that they are evenly distributed in developing
rat fetal lung among all cell types Jeanne M. Snyder,
.personal communication .
Though it appears that we have demonstrated only
modest changes in PKA activity associated with mat-
uration of the rat lung, there is precedence in the
literature to support the contention that these ob-
served changes may indeed be physiologically impor-
tant. For example, increases in PKA activity of 40%
 .induced by dibutyryl-cAMP 1 mM are associated
with the induction of morphological changes consis-
tent with differentiation of schwann cells in vitro
w x34 . We observed endogenous PKA activity in both
the 18-day and 20-day fetal lung to be approximately
30% and 55% higher than the PKA activity observed
in the newborn and 14-day newborn lung, respec-
 .tively Fig. 1 . This degree of difference in PKA
activity is similar to the 48% increase in PKA activ-
ity observed in isolated rat type II cells incubated in
 . w xthe presence of dibutyryl-cAMP 1 mM 33 . The
ability of this degree of change in PKA activity to
effect changes in the developing lung has been
demonstrated in models of rat, rabbit and human fetal
lung development. For example, the incubation of rat
fetal lung explants in the presence of dibutyryl-cAMP
 .200 mM stimulates choline incorporation into phos-
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w xphatidylcholine 6 , and the incubation of rabbit fetal
w x w xlung explants 35 and human fetal lung explants 7
 .in the presence of dibutyryl-cAMP 1 mM stimulates
increased levels of SP-A, and SP-A mRNA. Dibu-
 .tyryl-cAMP 1 mM also accelerates type II cell
differentiation and morphological change in human
w xfetal lung in vitro 7 . Taken together, these data
suggest that the changes in endogenous PKA activity
that we observed with rat lung development may
indeed be adequate to be responsible for physio-
logical changes in the developing lung.
Hormonal effects on PKA mRNA levels in the
developing lung have not been previously reported.
However, the hormonal regulation of PKA subunit
mRNA levels in other systems has been described
w xpreviously. Kurten et al. 36 reported that the in vitro
differentiation of preadipocytes to adipocytes is asso-
ciated with induction of the PKA subunits RIa , RIIb
and Ca . Dexamethasone treatment of the adipocytes
resulted in decreased levels of mRNA for Ca , RIa
and RIIb , whereas RIIb and Ca mRNA were in-
duced by the treatment of cultures with indomethacin,
w xan inhibitor of prostaglandin synthesis 36 . Basal
levels of RIa protein have been reported to be
responsible for the maintenance of cellular PKA ac-
w xtivity. Jones et al. 37 found human hepatoma cells
to contain only 10% of the RIa mRNA present in
other cultured cell types. This decrease in RIa mRNA
resulted in increased basal activity of PKA which,
they speculated, results in PKA mediated constitutive
w x hyperphosphorylation of CREB 37 . CREB CRE-bi-
.nding protein is a specific nuclear transcription fac-
tor required for cAMP induction and basal level
w xexpression of CRE-containing genes 38,39 . We did
not find a significant effect of dexamethasone on Ca
mRNA levels in rat fetal lung tissues maintained in
vitro. In contrast, RIa mRNA levels were signifi-
cantly decreased in tissues treated with dexametha-
sone. The fact that we did not observe a change in
PKA activity in association with a decrease in RIa
mRNA levels may be the result of the relatively
 .modest decrease in RIa mRNA levels 19% that we
observed. Thus, it is unlikely that this modest change
in RIa mRNA levels in response to glucocorticoids
is of physiological significance.
Endogenous PKA activity is determined by intra-
cellular cAMP levels, the relative amounts of regula-
tory and catalytic subunits, and the actions of endoge-
nous PKA inhibitors such as the thermostable protein
w xinhibitor of PKA, PKI 40 . The complexity of the
system increases when one considers the existence of
one or more isoforms for each of the PKA subunits
w xand for PKI 41 . Our finding of increased endoge-
nous PKA activity in the developing lung at 18 and
20 days of gestation suggests that all of the biochemi-
cal entities involved in determining PKA activity are
regulated in a fashion which optimizes the response
to cAMP in preparation for extrauterine life and air
breathing. The results of our investigation suggest the
developmental control of some or all of the factors
which regulate PKA activity. Our in vitro findings of
no change in PKA activity with dexamethasone treat-
ment in spite of a decrease in steady state levels of
 .mRNA for an important regulatory subunit RIa
supports the notion that cAMP action in the develop-
ing lung occurs independently of the influence of
glucocorticoids. The lack of influence by glucocorti-
coids on PKA activity does not rule out the possibil-
ity that our observed changes in PKA activity and
PKA mRNA expression are modulated by other, as
yet unidentified, factors in the developing lung. We
speculate that further work to determine the responsi-
ble regulatory factors and the mechanisms, whereby
their effects may permit one to pharmacologically
modulate the response of the developing lung to
cAMP.
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